2023
Use of immune checkpoint inhibitors in solid organ transplant recipients with advanced cutaneous malignancies
Ji S, Liu H, Pachella L, Stephenson R, Groisberg R, Weiss S. Use of immune checkpoint inhibitors in solid organ transplant recipients with advanced cutaneous malignancies. Frontiers In Transplantation 2023, 2: 1284740. PMID: 38993910, PMCID: PMC11235332, DOI: 10.3389/frtra.2023.1284740.Peer-Reviewed Original ResearchImmune checkpoint inhibitorsCutaneous squamous cell carcinomaObjective response rateMerkel cell carcinomaSolid organ transplant recipientsOrgan transplant recipientsSOT recipientsGraft rejectionCutaneous malignanciesCheckpoint inhibitorsTransplant recipientsCell carcinomaRetrospective analysisFirst-line immune checkpoint inhibitorsPrior systemic therapyAdvanced skin cancerSquamous cell carcinomaAdvanced cutaneous malignanciesImmunosuppressive therapyAllograft rejectionGraft failureSystemic therapyAdvanced melanomaCare therapyImmunosuppressive agents
2015
Role of the Medical Oncologist in the Management of Skin Cancer
Weiss S, Wilson M, Pavlick A. Role of the Medical Oncologist in the Management of Skin Cancer. Current Dermatology Reports 2015, 4: 205-212. DOI: 10.1007/s13671-015-0119-0.Peer-Reviewed Original ResearchMetastatic skin cancerMedical oncologistsCell carcinomaSkin cancerSquamous cell carcinomaMerkel cell carcinomaBasal cell carcinomaSystemic therapyLocal therapyMedical oncologySurgical oncologyField of dermatologyCancerCarcinomaOncologistsRadiation oncologyMedical specialistsOncologyTherapyMulti-disciplinary approachPertinent evidenceSurgeryMelanomaManagementRecurrent